A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas.
暂无分享,去创建一个
Yan Li | Yen Wei | Hai He | Yen Wei | Wan-Liang Lu | Xinru Jia | Jinning Lou | Jin-ning Lou | Xinru Jia | Hai He | Yan Li | W. Lu | Wan-Liang Lu
[1] E. Meijer,et al. The dendritic box, shape-selective liberation of encapsulated guests , 1995 .
[2] Donald A Tomalia,et al. Dendrimers in biomedical applications--reflections on the field. , 2005, Advanced drug delivery reviews.
[3] Sagar Agarwal,et al. Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain , 2011, Expert Reviews in Molecular Medicine.
[4] F. Szoka,et al. PEGylated dendrimers with core functionality for biological applications. , 2008, Bioconjugate chemistry.
[5] R. Kannan,et al. Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications. , 2010, Drug discovery today.
[6] Yan Zhang,et al. Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[7] M. Glatzel,et al. Efficient Chemotherapy of Rat Glioblastoma Using Doxorubicin-Loaded PLGA Nanoparticles with Different Stabilizers , 2011, PloS one.
[8] A. Chilkoti,et al. Structural optimization of a "smart" doxorubicin-polypeptide conjugate for thermally targeted delivery to solid tumors. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[9] W. Jefferies,et al. Transferrin receptor on endothelium of brain capillaries , 1984, Nature.
[10] G. Ellman,et al. Tissue sulfhydryl groups. , 1959, Archives of biochemistry and biophysics.
[11] T. Young,et al. Doxorubicin delivery by polyamidoamine dendrimer conjugation and photochemical internalization for cancer therapy. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[12] Rongrong Hua,et al. Lactoferrin-conjugated biodegradable polymersome holding doxorubicin and tetrandrine for chemotherapy of glioma rats. , 2010, Molecular pharmaceutics.
[13] Yang Yang,et al. A novel mixed micelle gel with thermo-sensitive property for the local delivery of docetaxel. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[14] R. Goodman,et al. Tamoxifen Paradoxically Decreases Paclitaxel Deposition into Cerebrospinal Fluid of Brain Tumor Patients , 2005, Journal of Neuro-Oncology.
[15] W. Hall. Transferrin receptor on glioblastoma multiforme. , 1991, Journal of Neurosurgery.
[16] Mark E. Davis,et al. Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.
[17] D. V. Kohli,et al. Transferrin coupled liposomes as drug delivery carriers for brain targeting of 5-florouracil , 2005, Journal of drug targeting.
[18] Mark W Grinstaff,et al. Biomedical applications of dendrimers: a tutorial. , 2011, Chemical Society reviews.
[19] A. Ballangrud,et al. Binding and interstitial penetration of liposomes within avascular tumor spheroids , 2004, International journal of cancer.
[20] E. Simanek,et al. Dendrimers as drug delivery vehicles: non-covalent interactions of bioactive compounds with dendrimers. , 2007, Polymer international.
[21] Yan Zhang,et al. Enhanced efficacy of functionalized epirubicin liposomes in treating brain glioma-bearing rats. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[22] W. Pardridge,et al. Drug and gene targeting to the brain with molecular trojan horses , 2002, Nature Reviews Drug Discovery.
[23] Yan Zhang,et al. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals. , 2009, Molecular pharmaceutics.
[24] Javed Ali,et al. Strategy for effective brain drug delivery. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[25] K. Plate,et al. Vascularization of human glioma spheroids implanted into rat cortex is conferred by two distinct mechanisms , 1999, Journal of neuroscience research.
[26] R. Kayyali,et al. Tamoxifen decreases drug efflux from liposomes: Relevance to its ability to reverse multidrug resistance in cancer cells? , 1994, FEBS letters.
[27] Y. Pei,et al. Partly PEGylated polyamidoamine dendrimer for tumor-selective targeting of doxorubicin: the effects of PEGylation degree and drug conjugation style. , 2010, Biomaterials.
[28] A. Salgado,et al. Dendrimers and derivatives as a potential therapeutic tool in regenerative medicine strategies—A review , 2010 .
[29] Hall Wa. Transferrin receptor on glioblastoma multiforme. , 1991 .
[30] Seung Jin Lee,et al. Penetration and efficacy of VEGF siRNA using polyelectrolyte complex micelles in a human solid tumor model in-vitro. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[31] David J. Begley,et al. Structure and function of the blood–brain barrier , 2010, Neurobiology of Disease.
[32] Mark W Grinstaff,et al. Dendrimer-encapsulated camptothecins: increased solubility, cellular uptake, and cellular retention affords enhanced anticancer activity in vitro. , 2006, Cancer research.
[33] J. Benoit,et al. Brain targeting using novel lipid nanovectors. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[34] Francis C Szoka,et al. Designing dendrimers for biological applications , 2005, Nature Biotechnology.
[35] P. Hildgen,et al. Methotrexate loaded polyether-copolyester dendrimers for the treatment of gliomas: enhanced efficacy and intratumoral transport capability. , 2008, Molecular pharmaceutics.
[36] C. Ferretti,et al. Tamoxifen counteracts estradiol induced effects on striatal and hypophyseal dopamine receptors. , 1988, Life sciences.
[37] W. Zhong,et al. Shell cross-linked and hepatocyte-targeting nanoparticles containing doxorubicin via acid-cleavable linkage. , 2011, Nanomedicine : nanotechnology, biology, and medicine.
[38] Z. Qian,et al. Transferrin/transferrin receptor-mediated drug delivery. , 2002, Medicinal research reviews.
[39] S. Kannan,et al. Poly(amidoamine) dendrimer-drug conjugates with disulfide linkages for intracellular drug delivery. , 2009, Biomaterials.
[40] Lisa Brannon-Peppas,et al. Active targeting schemes for nanoparticle systems in cancer therapeutics. , 2008, Advanced drug delivery reviews.
[41] P. Pávek,et al. Lack of Interactions between Breast Cancer Resistance Protein (BCRP/ABCG2) and Selected Antiepileptic Agents , 2006, Epilepsia.
[42] Kostas Kostarelos,et al. Functionalized-quantum-dot-liposome hybrids as multimodal nanoparticles for cancer. , 2008, Small.
[43] E. Simanek,et al. Reduction of drug toxicity using dendrimers based on melamine. , 2004, Molecular pharmaceutics.
[44] Whelan. NAALADase inhibitors: A novel approach to glutamate regulation. , 2000, Drug discovery today.
[45] J. Huwyler,et al. Brain drug delivery of small molecules using immunoliposomes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[46] J. Robert,et al. Inhibition of protein kinase C in multidrug-resistant cells by modulators of multidrug resistance , 2005, Journal of Cancer Research and Clinical Oncology.
[47] Xue Ying,et al. PEGylated Poly(amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors. , 2011, Biomaterials.
[48] H. Sarin. Recent progress towards development of effective systemic chemotherapy for the treatment of malignant brain tumors , 2009, Journal of Translational Medicine.